Abstract:IntroductionMicroneedling (MN) is a minimally invasive procedure involving the induction of percutaneous wounds with medical-grade needles. In this literature review, we investigate clinical data on MN for the treatment of hair loss disorders.MethodsA literature search was conducted through PubMed up to November 2021 to identify original articles evaluating the use of MN on hair loss disorders. The database was searched using the following keywords: “microneedling,” “micro needling,” “micro needle,” “microneedle,” “needle,” “dermaroller” and “alopecia,” “hair loss,” “alopecia,” “areata,” “cicatricial,” or “effluvium.”ResultsA total of 22 clinical studies featuring 1127 subjects met our criteria for inclusion. Jadad scores ranged from 1 to 3, with a mean of 2. As an adjunct therapy, MN improved hair parameters across genders and a range of hair loss types, severities, needling devices, needling depths of 0.50–2.50 mm, and session frequencies from once weekly to monthly. Across 17 investigations totaling 911 androgenic alopecia (AGA) subjects, MN improved hair parameters when paired with 5% minoxidil, growth factor solutions, and/or platelet-rich plasma (PRP) topicals, or when introduced to subjects whose hair count changes had plateaued for ≥ 6 months on other treatments. Across four investigations on 201 alopecia areata (AA) subjects, MN improved hair parameters as a standalone therapy versus cryotherapy, as an adjunct to 5-aminolevulinic acid and photodynamic therapy, and equivalently when paired with topical PRP versus carbon dioxide laser therapy with topical PRP. Across 657 subjects receiving MN, no serious adverse events were reported.ConclusionsClinical studies demonstrate generally favorable results for MN as an adjunct therapy for AGA and AA. However, data are of relatively low quality. Significant heterogeneity exists across interventions, comparators, and MN procedures. Large-scale randomized controlled trials are recommended to discern the effects of MN as a standalone and adjunct therapy, determine best practices, and establish long-term safety.

Microneedles along with conventional therapies: An in-depth observational review in alopecia areata treatment

Growth Factors and Microneedling in Alopecia Areata: A Narrative Review

Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system

Microneedling and Its Use in Hair Loss Disorders: A Systematic Review

Novel treatment of alopecia areata with shooting-type candlelit-dissolving microneedle

Dissolving microneedles for alopecia treatment

Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study

Microneedle‐mediated Delivery of Immunomodulators Restores Immune Privilege in Hair Follicles and Reverses Immune‐Mediated Alopecia

Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial

Advances in microneedles research based on promoting hair regrowth

Microneedle-mediated transdermal drug delivery for treating diverse skin diseases

Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report

Combining Rapid Degrading Microneedles with Slow-Released Drug Delivery System for the Treatment of Alopecia Areata

Microneedle transdermal delivery of compound betamethasone in alopecia areata-A randomized controlled trial

Microneedle applications in improving skin appearance

Emerging drugs for the treatment of alopecia areata

Microneedles as A Magical Technology to facilitate Transdermal Drug Delivery: A Review Article

A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: A pilot study

Novel drug delivery approaches for the management of hair loss

Effect of minoxidil combined with triamcinolone acetonide on alopecia areata by microneedle injection